Your session is about to expire
← Back to Search
Transpyloric Feeding for Very Low Birth Weight Infants
Study Summary
This trial will evaluate the feasibility and safety of transpyloric feeds in premature infants. The hypothesis is that transpyloric feeds may be safely and successfully performed in premature very low birth weight infants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My infant had intestinal issues or NEC.Your blood pH is less than 7.0.My infant has a birth defect, such as heart issues or structural problems.My infant has not started eating by mouth within 10 days of birth.A baby scored less than 5 on the APGAR test 5 minutes after birth.My infant is on hydrocortisone for low blood pressure before being assigned to a study group.My baby was born weighing less than 1251 grams.You have a tube in your stomach for feeding.My baby was born smaller than 90% of babies at the same number of weeks of pregnancy.Babies who are brought to Johns Hopkins All Children's NICU within 3 days of being born.
- Group 1: Duodenal Feeds
- Group 2: Gastric Feeds
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the recruitment phase of this clinical trial still active?
"Records on clinicaltrials.gov indicate that this experiment is actively recruiting test subjects, having initially been posted on August 7th 2020 and subsequently revised on June 6th 2022."
Which patient demographic is authorized to participate in this experiment?
"Currently, 30 neonates are being accepted for this trial; to be eligible, babies must have been born prematurely and fall within the 0 Day - 12 Month age range."
How many participants is the maximum capacity for this clinical trial?
"Affirmative. According to the information provided through clinicaltrials.gov, this particular medical experiment is actively looking for participants from a single trial location and has opened recruitment since its initial posting on August 7th of 2020. The most recent update occurred on June 6th 2022 and the study seeks 30 patients in total."
Does this research endeavor accept elderly participants?
"This clinical trial is limited to participants between 0 days and 12 months old. 335 studies are available for individuals who have not yet reached the age of majority, while 478 trials can be accessed by seniors aged 65 or older."
Share this study with friends
Copy Link
Messenger